Research Articles
Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.
| Article Title | Original Publication Date | Journal | Bone Marrow Disease |
|---|---|---|---|
| Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Nov 2020 | Annals of Oncology: Official Journal of the European Society for Medical Oncology | Myelodysplastic Syndromes (MDS) |
| Myelodysplastic Syndromes: Moving Towards Personalized Management | May 2020 | Haematologica | Myelodysplastic Syndromes (MDS) |
| Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? | Jun 2020 | Best practice & research. Clinical haematology | Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
| Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes | Jun 2023 | European Journal of Haematology | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| New Approaches for Anemia in MDS | Sep 2020 | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |
| New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes | May 2025 | American Society of Clinical Oncology Educational Book | Myelodysplastic Syndromes (MDS) |
| New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes | Jun 2025 | American Society of Clinical Oncology Educational Book | Myelodysplastic Syndromes (MDS) |
| Newly revised 2023 MDS response criteria | Apr 2023 | Blood | Myelodysplastic Syndromes (MDS) |
| Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment | May 2023 | The Cancer Journal | Myelodysplastic Syndromes (MDS) |
| Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria | Jul 2023 | Clinical and Experimental Medicine | Paroxysmal Nocturnal Hemoglobinuria (PNH) |